A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder
Clinical trial NCT06796868 · COMPLETED
Trial details
- NCT number
- NCT06796868
- Sponsor
- Beijing Greatway Pharmaceutical Technology Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2023-09-28
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.